Therapeutic Approach

Archive: January, 2014

Ritter Pharmaceuticals Announces Publication of Lactose Intolerance Phase 2 Trial in Nutrition Journal

Marks scientific publication of first Investigational New Drug treatment for LI LOS ANGELES, Calif., January 8, 2014 – Ritter Pharmaceuticals, Inc. today announced that Nutrition Journal has published the results of its Phase 2 trial of RP-G28, a proprietary oligosaccharide under investigation as a potential treatment for lactose intolerance. The study manuscript entitled, “Improving lactose […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD